What is Tempus?
Tempus is at the forefront of making precision medicine a reality by leveraging artificial intelligence within the healthcare sector. The company harnesses its expansive library of clinical and molecular data to derive critical insights, enabling physicians to make real-time, data-driven decisions. This analytical machine learning platform facilitates the delivery of personalized care and targeted therapies for patients. Tempus also collaborates with partners to accelerate the discovery, development, and delivery of optimized therapeutic options, offering distinctive solution sets that integrate AI in healthcare.
How much funding has Tempus raised?
Tempus has raised a total of $2.1B across 12 funding rounds:
Series B
$50M
Series C
$70M
Series D
$80M
Series E
$110M
Series F
$200M
Multiple Rounds
$550M
Other Financing Round
$275M
Stock Offering
$410.7M
Debt
$300M
Series B (2017): $50M, investors not publicly disclosed
Series C (2017): $70M supported by New Enterprise Associates and Revolution Growth
Series D (2018): $80M featuring T. Rowe Price and Revolution Growth
Series E (2018): $110M backed by Baillie Gifford, Revolution Growth, T. Rowe Price, and New Enterprise Associates
Series F (2019): $200M with participation from Baillie Gifford, T. Rowe Price, New Enterprise Associates, Revolution Growth, Franklin Templeton Investments, and Novo Holdings
Series G (2020): $200M led by Novo Holdings, Franklin Templeton, Baillie Gifford, T. Rowe Price, and NEA
Other Financing Round (2020): $100M, investors not publicly disclosed
Debt (2020): $250M, investors not publicly disclosed
Other Financing Round (2022): $275M backed by Ares Capital
Stock Issuance/Offering (2024): $410.7M, investors not publicly disclosed
Debt (2025): $300M led by Ares Management Corporation
Key Investors in Tempus
New Enterprise Associates
New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, known for its focus on helping entrepreneurs build businesses and investing in early-stage companies.
Revolution Growth
Revolution is a venture capital firm that invests in transformative technologies and iconic destinations, supporting entrepreneurs who are redefining possibilities and promoting innovation.
Franklin Templeton
Franklin Templeton is a global investment management organization offering expertise across multiple asset classes, including equity, fixed income, and alternatives, serving clients worldwide.
What's next for Tempus?
The substantial enterprise-level funding and strategic investments indicate that Tempus is in a robust scaling phase, poised for significant expansion and innovation. Future endeavors will likely focus on further developing its AI-driven healthcare platform, broadening its data acquisition efforts, and forging new strategic partnerships to enhance therapeutic development. The company's trajectory suggests a continued commitment to revolutionizing patient care through data-intensive, AI-powered solutions, solidifying its position as a leader in the health-tech industry.
See full Tempus company page
